MétaCan
Menu
Back to cohort
Record W2945359516 · doi:10.1016/s0167-8140(19)30475-x

OC-0055 Zebrafish model to study the use of nanoparticles as a radiosensitizer in low Z target beams

2019· article· en· W2945359516 on OpenAlexaff
Mina Ha, Olivia Piccolo, Nicole Melong, John R. Lincoln, David Parsons, Alexandre Detappe, Olivier Tillement, Ross Berbeco, Jason N. Berman, James L. Robar

Bibliographic record

VenueRadiotherapy and Oncology · 2019
Typearticle
Languageen
FieldMedicine
TopicRadiation Therapy and Dosimetry
Canadian institutionsDalhousie University
Fundersnot available
KeywordsRadiosensitizerZebrafishMedicineChemistryInternal medicineRadiation therapyBiochemistry

Abstract

fetched live from OpenAlex

Several clinical studies have shown the possibilities to give a higher dose to certain hypothetically more radioresistant tumour sub-volumes, typically with high accumulation of FDG or a hypoxia tracer.We have tested the therapeutic efficacy of dose-painting (DP) strategies, i.e. targeted dose escalation and dose redistribution, in a rat syngeneic rhabdomyosarcoma model based on FDG uptake [1].Our data indicate that, while dose escalation to high FDG uptake sub-volume was not superior to the same dose increase in low FDG uptake areas, dose redistribution was even detrimental, consistent with the hypothesis that tumor response is dependent on the minimum intratumoral dose.Interestingly, in the same tumour model dose escalation to the hypoxic sub-volume, as determined by the highest uptake of HX4 hypoxia tracer, resulted in worse tumour response than the same dose increment to the non-hypoxic sub-volume [2].This data suggests that dose to the tumour bulk should be sufficient to inactivate non-hypoxic cells.It might be difficult to achieve clinically sufficient dose escalation to eradicate tumour cells in hypoxic tumor subvolume.Therefore, we moved beyond the traditional DP approaches combining hypoxia-targeted drugs with inverse dose-painting of hypoxic sub-volume and thus offering, in our view, more efficient utilization of radiation, i.e. radiation boost to non-hypoxic tumour areas with simultaneous inactivation of hypoxic tumour cells by a HAP.Indeed, our results support targeted dose escalation to non-hypoxic sub-volume with no/low activity of HAPs.This strategy applies on average a lower radiation dose and is as effective as uniform dose escalation to the entire tumour.Routine implementation particularly of hypoxia PET imaging in the clinic is problematic because it is expensive, labor intensive, not attractive for the patient, or even not accessible.Therefore, partial non-targeted tumour irradiation with high dose in combination with immunotherapy might be a new alternative approach to dose-painting, which is currently being tested in our laboratory.It is expected that partial tumour irradiation enables delivery of high doses to tumor sub-volumes reducing normal tissue injury, causes less total damage to intratumoral vasculature permitting immune cells infiltration and provides stronger induction of immunogenic cell death releasing antigens and stimulants to immune system, while immunotherapy boosts antitumour immune response with systemic therapeutic potential.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.010
Threshold uncertainty score0.020

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.028
GPT teacher head0.312
Teacher spread0.284 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractno

Explore more

Same venueRadiotherapy and OncologySame topicRadiation Therapy and DosimetryFrench-language works237,207